Literature DB >> 29404877

O-GlcNAc: a novel regulator of immunometabolism.

Miranda Machacek1,2, Chad Slawson2, Patrick E Fields3.   

Abstract

The rapidly expanding field of immunometabolism focuses on how metabolism controls the function of immune cells. CD4+ T cells are essential for the adaptive immune response leading to the eradication of specific pathogens. However, when T cells are inappropriately over-active, they can drive autoimmunity, allergic disease, and chronic inflammation. The mechanisms by which metabolic changes influence function in CD4+ T cells are not fully understood. The post-translational protein modification, O-GlcNAc (O-linked β-N-acetylglucosamine), dynamically cycles on and off of intracellular proteins as cells respond to their environment and flux through metabolic pathways changes. As the rate of O-GlcNAc cycling fluctuates, protein function, stability, and/or localization can be affected. Thus, O-GlcNAc is critically poised at the nexus of cellular metabolism and function. This review highlights the intra- and extracellular metabolic factors that influence CD4+ T cell activation and differentiation and how O-GlcNAc regulates these processes. We also propose areas of future research that may illuminate O-GlcNAc's role in the plasticity and pathogenicity of CD4+ T cells and uncover new potential therapeutic targets.

Entities:  

Keywords:  Inflammation; Metabolic regulation; O-GlcNAc; T cells

Mesh:

Substances:

Year:  2018        PMID: 29404877      PMCID: PMC6408937          DOI: 10.1007/s10863-018-9744-1

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  55 in total

1.  Phosphorylation and O-linked glycosylation of Elf-1 leads to its translocation to the nucleus and binding to the promoter of the TCR zeta-chain.

Authors:  Yuang-Taung Juang; Elena E Solomou; Barbara Rellahan; George C Tsokos
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

2.  TH17 cell differentiation is regulated by the circadian clock.

Authors:  Xiaofei Yu; Darcy Rollins; Kelly A Ruhn; Jeremy J Stubblefield; Carla B Green; Masaki Kashiwada; Paul B Rothman; Joseph S Takahashi; Lora V Hooper
Journal:  Science       Date:  2013-11-08       Impact factor: 47.728

3.  Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation.

Authors:  Valerie A Gerriets; Rigel J Kishton; Amanda G Nichols; Andrew N Macintyre; Makoto Inoue; Olga Ilkayeva; Peter S Winter; Xiaojing Liu; Bhavana Priyadharshini; Marta E Slawinska; Lea Haeberli; Catherine Huck; Laurence A Turka; Kris C Wood; Laura P Hale; Paul A Smith; Martin A Schneider; Nancie J MacIver; Jason W Locasale; Christopher B Newgard; Mari L Shinohara; Jeffrey C Rathmell
Journal:  J Clin Invest       Date:  2014-12-01       Impact factor: 14.808

4.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.

Authors:  Ruoning Wang; Christopher P Dillon; Lewis Zhichang Shi; Sandra Milasta; Robert Carter; David Finkelstein; Laura L McCormick; Patrick Fitzgerald; Hongbo Chi; Joshua Munger; Douglas R Green
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

Review 5.  Activation of the Ets transcription factor Elf-1 requires phosphorylation and glycosylation: defective expression of activated Elf-1 is involved in the decreased TCR zeta chain gene expression in patients with systemic lupus erythematosus.

Authors:  George C Tsokos; Madhusoodana P Nambiar; Yuang-Taung Juang
Journal:  Ann N Y Acad Sci       Date:  2003-04       Impact factor: 5.691

6.  Obesity Drives Th17 Cell Differentiation by Inducing the Lipid Metabolic Kinase, ACC1.

Authors:  Yusuke Endo; Hikari K Asou; Nao Matsugae; Kiyoshi Hirahara; Kenta Shinoda; Damon J Tumes; Hirotake Tokuyama; Koutaro Yokote; Toshinori Nakayama
Journal:  Cell Rep       Date:  2015-07-30       Impact factor: 9.423

7.  De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells.

Authors:  Luciana Berod; Christin Friedrich; Amrita Nandan; Jenny Freitag; Stefanie Hagemann; Kirsten Harmrolfs; Aline Sandouk; Christina Hesse; Carla N Castro; Heike Bähre; Sarah K Tschirner; Nataliya Gorinski; Melanie Gohmert; Christian T Mayer; Jochen Huehn; Evgeni Ponimaskin; Wolf-Rainer Abraham; Rolf Müller; Matthias Lochner; Tim Sparwasser
Journal:  Nat Med       Date:  2014-10-05       Impact factor: 53.440

Review 8.  Pathogenic Role of IL-17-Producing Immune Cells in Obesity, and Related Inflammatory Diseases.

Authors:  Marwa Chehimi; Hubert Vidal; Assia Eljaafari
Journal:  J Clin Med       Date:  2017-07-14       Impact factor: 4.241

9.  The AGC kinase SGK1 regulates TH1 and TH2 differentiation downstream of the mTORC2 complex.

Authors:  Emily B Heikamp; Chirag H Patel; Sam Collins; Adam Waickman; Min-Hee Oh; Im-Hong Sun; Peter Illei; Archna Sharma; Aniko Naray-Fejes-Toth; Geza Fejes-Toth; Jyoti Misra-Sen; Maureen R Horton; Jonathan D Powell
Journal:  Nat Immunol       Date:  2014-04-06       Impact factor: 25.606

10.  Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancy.

Authors:  Mahima Swamy; Shalini Pathak; Katarzyna M Grzes; Sebastian Damerow; Linda V Sinclair; Daan M F van Aalten; Doreen A Cantrell
Journal:  Nat Immunol       Date:  2016-04-25       Impact factor: 25.606

View more
  8 in total

Review 1.  O-GlcNAcylation: The Underestimated Emerging Regulators of Skeletal Muscle Physiology.

Authors:  Yang Liu; Ya-Jie Hu; Wen-Xuan Fan; Xin Quan; Bin Xu; Shi-Ze Li
Journal:  Cells       Date:  2022-05-30       Impact factor: 7.666

2.  Inhibition of O-GlcNAcylation Decreases the Cytotoxic Function of Natural Killer Cells.

Authors:  Daniel Feinberg; Parameswaran Ramakrishnan; Derek P Wong; Abhishek Asthana; Reshmi Parameswaran
Journal:  Front Immunol       Date:  2022-04-11       Impact factor: 8.786

3.  Apart From Rhoptries, Identification of Toxoplasma gondii's O-GlcNAcylated Proteins Reinforces the Universality of the O-GlcNAcome.

Authors:  Moyira Osny Aquino-Gil; Mattis Kupferschmid; Hosam Shams-Eldin; Jörg Schmidt; Nao Yamakawa; Marlène Mortuaire; Frédéric Krzewinski; Stéphan Hardivillé; Edgar Zenteno; Christian Rolando; Fabrice Bray; Eduardo Pérez Campos; Jean-François Dubremetz; Yobana Perez-Cervera; Ralph T Schwarz; Tony Lefebvre
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-20       Impact factor: 5.555

Review 4.  O-GlcNAcylation in immunity and inflammation: An intricate system (Review).

Authors:  Yu Li; Mingzheng Xie; Lili Men; Jianling Du
Journal:  Int J Mol Med       Date:  2019-06-11       Impact factor: 4.101

Review 5.  Targeting Protein O-GlcNAcylation, a Link between Type 2 Diabetes Mellitus and Inflammatory Disease.

Authors:  Israel Olapeju Bolanle; Timothy M Palmer
Journal:  Cells       Date:  2022-02-17       Impact factor: 6.600

Review 6.  The Beginner's Guide to O-GlcNAc: From Nutrient Sensitive Pathway Regulation to Its Impact on the Immune System.

Authors:  Michael P Mannino; Gerald W Hart
Journal:  Front Immunol       Date:  2022-01-31       Impact factor: 7.561

7.  Deep learning explains the biology of branched glycans from single-cell sequencing data.

Authors:  Rui Qin; Lara K Mahal; Daniel Bojar
Journal:  iScience       Date:  2022-09-19

8.  Inhibition of O-GlcNAc Transferase Alters the Differentiation and Maturation Process of Human Monocyte Derived Dendritic Cells.

Authors:  Matjaž Weiss; Marko Anderluh; Martina Gobec
Journal:  Cells       Date:  2021-11-26       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.